Abstract
Rationale
The thyroid hormones (T3 and T4) play a critical role in brain development, and thyroid abnormalities have been linked to a variety of psychiatric and neuropsychological disorders. Among patients with the rare genetic syndrome resistance to thyroid hormone (RTH), 40–70% meet the diagnostic criteria for attention deficit-hyperactivity disorder (ADHD). RTH is caused by a mutation in the thyroid receptor β (Thrb) gene that results in reduced binding of T3 to its receptor and elevated concentrations of T3, T4, and thyroid-stimulating hormone.
Objectives
We tested a knock-in (KI) mouse expressing a mutant TRβ allele (TRβPV) for the behavioral features of ADHD and their response to methylphenidate (MPH).
Methods
The locomotor activity of the TRβPV KI mice was measured in activity monitors over multiple sessions. Sustained attention and the effects of MPH on attention were assessed using a vigilance task.
Results
The TRβPV KI mice are hyperactive and have learning deficits on a vigilance task. Doses of MPH that impair the vigilance performance of wild-type mice do not affect the performance of the TRβPV KI mice.
Conclusions
The TRβPV KI mice provide a tool for studying the underlying neural deficits that contribute to thyroid-related neurological disorders, hyperactivity, and altered responsiveness to MPH.
Similar content being viewed by others
References
Agarwal RA, Rastogi RB, Singhal RL (1976) Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone. Res Commun Chem Pathol Pharmacol 15:743–752
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
Andersen SL, Teicher MH (2000) Sex differences in dopamine receptors and their relevance to ADHD. Neurosci Biobehav Rev 24:137–141
Andersen SL, Rutstein M, Benzo J, Hostetter JC, Teicher MH (1997) Sex differences in dopamine receptor overproduction and elimination. NeuroReport 8:1495–1498
Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, Wilens TE, Frazier E, Johnson MA (2002) Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 159:36–42
Bodenner DL, Lash RW (1998) Thyroid disease mediated by molecular defects in cell surface and nuclear receptors. Am J Med 105:524–538
Broerson LM, Uylings HB (1999) Visual attention task performance in Wistar and Listar hooded rats: response inhibition deficits after medial prefrontal cortex lesions. Neuroscience 94:47–57
Chan S, Kilby MD (2000) Thyroid hormone and central nervous system development. J Endocrinol 165:1–8
Chudasama Y, Muir JL (2001) Visual attention in the rat: a role for the prelimbic cortex and thalamic nuclei? Behav Neurosci 2:417–428
Claustre J, Balende C, Pujol JF (1996) Influence of thyroid hormone status on tyrosine hydroxylase in central and peripheral catecholaminergic structures. Neurochem Int 28:277–281
Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL (1995) Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993–998
Davids E, Zhang K, Kula NS, Tarazi FI, Baldessarini RJ (2002) Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. J Pharmacol Exp Ther 301:1097–1102
De Bruin NMWJ, Kiliaan AJ, De Wilde MC, Broersen LM (2003) Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats. Neurobiol Learn Mem 80:63–79
Demet MM, Ozmen B, Deveci A, Boyvada S, Adiguzel H, Aydemir O (2002) Depression and anxiety in hyperthyroidism. Arch Med Res 33:552–556
Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397–401
Gaub M, Carlson CL (1997) Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psych 36:1036–1045
Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M (1997) Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 2:311–313
Goldman LS, Genel M, Bezman RJ, Slanetz PJ (1998) Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. J Am Med Assoc 279:1100–1107
Hauser P, Zametkin AJ, Martinez P, Vitiello B, Matochik JA, Mixson JA, Weintraub BD (1993) Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med 328:997–1001
Himelstein J, Schulz KP, Newcorn JH, Halperin JM (2000) The neurobiology of attention-deficit hyperactivity disorder. Front Biosci 5:461–478
Hridina PD, Ghosh PK, Rastogi RB, Singhal RL (1975) Ontogenic pattern of dopamine, acetylcholine, and acetylcholinesterase in the brains of normal and hypothyroid rats. Can J Physiol Pharm 53:709–715
Ito JM, Valcana T, Timiras PS (1997) Effect of hypo- and hyperthyroidism on regional monoamine metabolism in the adult rat brain. Neuroendocrinology 24:55–64
Kaneshige M, Kaneshige K, Zhu X, Dace A, Garrett L, Carter TA, Kazlauskaite R, Pankratz DG, Wynshaw-Boris A, Refetoff S, Weintraub B, Willingham MC, Barlow C, Cheng S-Y (2000) Mice with a targeted mutation in the thyroid hormone β receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci U S A 97:13209–13214
Kincaid AE (2001) Spontaneous circling behavior and dopamine neuron loss in a genetically hypothyroid mouse. Neuroscience 105:891–898
Klein C, Fischer B Jr, Fischer B, Hartnegg K (2002) Effects of methylphenidate on saccadic responses in patients with ADHD. Exp Brain Res 145:121–125
Kooistra L, van der Meere JJ, Vulsma T, Kalverboer AF (1996) Sustained attention problems in children with early-treated congenital hypothyroidism. Acta Paediatr 85:425–429
Kopp P, Kitajima K, Jameson JL (1996) Syndrome of resistance to thyroid hormone: insights into thyroid hormone action. Proc Soc Exp Biol Med 211:49–61
LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL (1996) Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1:121–124
Lee IT, Sheu WH, Liau YJ, Lin SY, Lee WJ, Lin CC (2003) Relationship of stressful life events, anxiety and depression to hyperthyroidism in an Asian population. Horm Res 60:247–251
Leonard CM, Martinez P, Weintraub BD, Hauser P (1995) Magnetic resonance imaging of cerebral anomalies in subjects with resistance to thyroid hormone. Am J Med Genet 60:238–243
Manor I, Corbex M, Eisenberg J, Gritsensko I, Bachner-Melman R, Tyrano S, Ebstein RP (2004) Association of the dopamine D5 receptor with attention-deficit/hyperactivity disorder (ADHD) and scores on a continuous performance test (TOVA). Am J Med Genet 127B:73–77
Matochik JA, Zametkin AJ, Cohen RM, Hauser P, Weintraub BD (1996) Abnormalities in sustained attention and anterior cingulate metabolism in subjects with resistance to thyroid hormone. Brain Res 723:23–28
McDonald MP, Wong R, Goldstein G, Weintraub B, Cheng S-Y, Crawley JN (1998) Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone β1 receptor gene. Learn Memory 5:289–301
McGaughy J, Sarter M (1995) Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology 117:340–357
Oades RD (2002) Dopamine may be ‘hyper’ with respect to noradrenaline metabolism, but ‘hypo’ with respect to serotonin metabolism in children with attention-deficit/hyperactivity disorder. Behav Brain Res 130:97–102
Pliszka SR (1998) Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatry 59(Suppl 7):50–58
Pliszka SR (2000) Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 9:525–540, vii
Rapaport JL, Buchsbaum MS, Weingartner H, Zahn TP, Ludlow C, Mikkelson EJ (1980) Dextroamphetamine: its cognitive and behavioral effects in normal and hyperactive boys and men. Arch Gen Psychiatry 37:933–943
Rastogi RB, Singhal RL (1974) Alterations in brain norepinephrine and tyrosine hydroxylase activity during experimental hypothyroidism in rats. Brain Res 81:253–266
Rastogi R, Singhal RL (1976) Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine, 5-hydroxytryptamine in rat brain. J Pharmacol Exp Ther 198:609–618
Rhodes JS, Garland T (2003) Differential sensitivity to acute administration of Ritalin, apomorphine, SCH 23390, but not raclopride in mice selectively bred for hyperactive wheel-running behavior. Psychopharmacology 167:242–250
Richardson E, Kupietz SS, Winsberg BG, Maitinsky S, Mendell N (1988) Effects of methylphenidate dosage in hyperactive reading-disabled children: II. Reading achievement. J Am Acad Child Adolesc Psych 27:78–87
Rovet J (1999) Congenital hypothyroidism: long-term outcome. Thyroid 9:741–748
Rovet J (2002) Congenital hypothyroidism: an analysis of persisting deficits and associated factors. Child Neuropsychol 8:150–162
Rovet J, Alvarez M (1996) Thyroid hormone and attention in school-age children with congenital hypothyroidism. J Child Psychol Psychiatry 37:579–585
Rovet J, Daneman D (2003) Congenital hypothyroidism: a review of current diagnostic and treatment practices in relation to neuropsychologic outcome. Paediatr Drugs 5:141–149
Sagvolden T (2000) Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 24:31–39
Solanto M (2002) Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav Brain Res 130:65–71
Song S-I, Daneman D, Rovet J (2001) The influence of etiology and treatment factors on intellectual outcome in congenital hypothyroidism. Dev Behav Pediatr 22:376–384
Stein MA, Weiss RE, Refetoff S (1995) Neurocognitive characteristics of individuals with resistance to thyroid hormone: comparisons with individuals with attention-deficit hyperactivity disorder. J Dev Behav Pediatr 16:406–411
Suzuki H, Willingham MC, Cheng S-Y (2002) Mice with a mutation in the thyroid hormone receptor β gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. Thyroid 12:963–969
Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg E, Wogal T, Lerner M, Williams L, LaHoste GJ, Wigal S (1998) Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family based approach. Mol Psychiatry 3:38–41
Thompson CC, Potter GB (2000) Thyroid hormone action in neural development. Cereb Cortex 10:939–945
Trommer BL, Hoeppner JA, Lorber R, Armstrong KJ (1988) The go–no-go paradigm in attention deficit disorder. Ann Neurol 24:610–614
Wong R, Vasilyev VV, Ting YT, Kutler DI, Willingham MC, Weintraub BD, Cheng S (1997) Transgenic mice bearing a human mutant thyroid beta 1 receptor manifest thyroid function anomalies, weight reduction, and hyperactivity. Mol Med 3:303–314
Zhang X-Y, Kaneshige M, Kamiya Y, Kaneshige K, McPhie P, Cheng S-Y (2002) Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant β receptor. Mol Endocrinol 16:2077–2092
Acknowledgements
The authors wish to thank Isha Dhringa, Andrew Misfeldt, and Jiali Zhao for technical assistance, Nicole Schramm for comments on the manuscript, and Warren Lambert for advice on statistical analysis. These experiments comply with the current laws of the country in which they were performed and with the principles of laboratory animal care.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Siesser, W.B., Cheng, Sy. & McDonald, M.P. Hyperactivity, impaired learning on a vigilance task, and a differential response to methylphenidate in the TRβPV knock-in mouse. Psychopharmacology 181, 653–663 (2005). https://doi.org/10.1007/s00213-005-0024-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-005-0024-5